Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Treatment of hepatitis C virus genotype 4 in the DAA era.

Di Biagio A, Taramasso L, Cenderello G.

Virol J. 2018 Nov 22;15(1):180. doi: 10.1186/s12985-018-1094-4. Review.

2.

HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation.

Cenderello G, Taramasso L, Marra D, Orcamo P, Pasa A, Di Biagio A.

Expert Rev Pharmacoecon Outcomes Res. 2018 Oct 15:1-5. doi: 10.1080/14737167.2019.1537124. [Epub ahead of print]

PMID:
30321071
3.

A case report of mucocutaneous tuberculosis after orthotopic liver transplantation: a challenging diagnosis.

Riccardi N, Cenderello G, Borroni E, Rutigliani M, Cirillo DM.

BMC Infect Dis. 2018 Aug 29;18(1):431. doi: 10.1186/s12879-018-3347-7.

4.

Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis.

Mangia A, Losappio R, Cenderello G, Potenza D, Mazzola M, De Stefano G, Terreni N, Copetti M, Minerva N, Piazzola V, Bacca D, Palmieri V, Sogari F, Santoro R.

PLoS One. 2018 Jul 31;13(7):e0200568. doi: 10.1371/journal.pone.0200568. eCollection 2018.

5.

Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study.

Focà E, Cavaglià G, Rusconi S, Cascavilla A, Cenderello G, Re A, Casari S, van den Bogaart L, Zinzani PL, Caracciolo D, Di Perri G, Bonito A, Lucchini A, Cassola G, Viale P, Calcagno A.

HIV Med. 2018 Jun 4. doi: 10.1111/hiv.12624. [Epub ahead of print]

PMID:
29862615
6.

Does simplification to dolutegravir-based dual regimens impact on the CD4+/CD8+ T-cell ratio?

Capetti AF, Orofino G, Paladini L, Sterrantino G, DiGiambenedetto S, De Socio GV, Cenderello G, Cossu MV, Rizzardini G.

AIDS. 2018 May 15;32(8):1083-1084. doi: 10.1097/QAD.0000000000001784. No abstract available.

PMID:
29698323
7.

Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review.

Goossens N, de Vito C, Mangia A, Clément S, Cenderello G, Barrera F, D'Ambrosio R, Coppola N, Zampino R, Stanzione M, Adinolfi LE, Wedemeyer H, Semmo N, Müllhaupt B, Semela D, Malinverni R, Moradpour D, Heim M, Trincucci G, Rubbia-Brandt L, Negro F; BOSTIC Study Group.

J Viral Hepat. 2018 Aug;25(8):920-929. doi: 10.1111/jvh.12891. Epub 2018 Apr 17. Review.

PMID:
29532619
8.

Hypertensive Versus HIV-infected Patients: Who Has the Greatest Target Organ Damage? Comparison of Carotid Plaque Prevalence, Intima Media Thickness and Renal Resistive Index in the Two Groups of Patients.

Taramasso L, Mirabella M, Cappadona F, Bonino B, Riccardi N, Cenderello G, De Socio GV, Viscoli C, Viazzi F, Di Biagio A.

Curr Hypertens Rev. 2018;14(1):48-55. doi: 10.2174/1573402114666180307145051.

PMID:
29521243
9.

From Liguria HIV Web to Liguria Infectious Diseases Network: How a Digital Platform Improved Doctors' Work and Patients' Care.

Giannini B, Riccardi N, Cenderello G, Di Biagio A, Dentone C, Giacomini M.

AIDS Res Hum Retroviruses. 2018 Mar;34(3):239-240. doi: 10.1089/aid.2017.0064. Epub 2018 Feb 21. No abstract available.

PMID:
29466022
10.

Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing.

Riccardi N, Giannini B, Borghesi ML, Taramasso L, Cattaneo E, Cenderello G, Toscanini F, Giacomini M, Pontali E, Cassola G, Viscoli C, Di Biagio A.

ERJ Open Res. 2018 Feb 2;4(1). pii: 00108-2017. doi: 10.1183/23120541.00108-2017. eCollection 2018 Jan.

11.

CD8+CD28-CD127loCD39+ regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?

Fenoglio D, Dentone C, Signori A, Di Biagio A, Parodi A, Kalli F, Nasi G, Curto M, Cenderello G, De Leo P, Bartolacci V, Orofino G, Nicolini LA, Taramasso L, Fiorillo E, Orrù V, Traverso P, Bruzzone B, Ivaldi F, Mantia E, Guerra M, Negrini S, Giacomini M, Bhagani S, Filaci G.

J Allergy Clin Immunol. 2018 Jun;141(6):2220-2233.e4. doi: 10.1016/j.jaci.2017.08.021. Epub 2017 Nov 2.

12.

Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus.

Castagna A, Ferrara M, Galli L, Comi L, Sterrantino G, Cenderello G, Zaccarelli M, Focà E, Roncadori A, Lazzarin A; PRESTIGIO Study Group.

J Antimicrob Chemother. 2018 Jan 1;73(1):177-182. doi: 10.1093/jac/dkx371.

PMID:
29077927
13.

Role of Raltegravir in patients co-infected with HIV and HCV in the era of direct antiviral agents.

Taramasso L, Cenderello G, Riccardi N, Tunesi S, Di Biagio A.

New Microbiol. 2017 Oct;40(4):227-233. Epub 2017 Oct 10. Review.

14.

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data.

Capetti AF, Cossu MV, Orofino G, Sterrantino G, Cenderello G, De Socio GV, Cattelan AM, Soria A, Rusconi S, Riccardi N, Baldin GM, Niero FP, Barbarini G, Rizzardini G.

BMC Infect Dis. 2017 Sep 30;17(1):658. doi: 10.1186/s12879-017-2755-4.

15.

Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion-dependent thalassaemia and HCV genotype 1 or 4 infection.

Mangia A, Sarli R, Gamberini R, Piga A, Cenderello G, Piazzolla V, Santoro R, Caruso V, Quarta A, Ganga R, Copetti M, Forni G.

Aliment Pharmacol Ther. 2017 Aug;46(4):424-431. doi: 10.1111/apt.14197. Epub 2017 Jun 29.

PMID:
28660640
16.

Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis.

Cenderello G, Fanizza C, Marenco S, Nicolini LA, Artioli S, Baldissarro I, Dentone C, De Leo P, Di Biagio A.

Clinicoecon Outcomes Res. 2017 May 22;9:281-293. doi: 10.2147/CEOR.S129859. eCollection 2017.

17.

A Web Based Tool to Enhance Monitoring and Retention in Care for Tuberculosis Affected Patients.

Giannini B, Riccardi N, Di Biagio A, Cenderello G, Giacomini M.

Stud Health Technol Inform. 2017;237:204-208.

PMID:
28479569
18.

Correction: Salvage therapy or simplification of salvage regimens with dolutegravir plus ritonavir-boosted darunavir dual therapy in highly cART-experienced subjects: an Italian cohort.

Capetti AF, Sterrantino G, Cossu MV, Cenderello G, Cattelan AM, De Socio GV, Rusconi S, Riccardi N, Baldin GM, Cima S, Niero FP, Rizzardini G, Sasset L.

Antivir Ther. 2017;22(3):273-275. doi: 10.3851/IMP3109. Epub 2016 Nov 28. No abstract available.

PMID:
28400541
19.

Is it still worthwhile to perform quarterly cd4+ t lymphocyte cell counts on hiv-1 infected stable patients?

Di Biagio A, Ameri M, Sirello D, Cenderello G, Di Bella E, Taramasso L, Giannini B, Giacomini M, Viscoli C, Cassola G, Montefiori M.

BMC Infect Dis. 2017 Feb 6;17(1):127. doi: 10.1186/s12879-017-2199-x.

20.

Quality of life in an Italian cohort of people living with HIV in the era of combined antiretroviral therapy (Evidence from I.A.N.U.A. study-investigation on antiretroviral therapy).

Venturini A, Cenderello G, Di Biagio A, Giannini B, Ameri M, Giacomini M, Montefiori M, Setti M, Mazzarello G, Merlano C, Orcamo P, Viscoli C, Cassola G.

AIDS Care. 2017 Nov;29(11):1373-1377. doi: 10.1080/09540121.2017.1286286. Epub 2017 Feb 2.

PMID:
28150510
21.

Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc.

Dentone C, Sterrantino G, Signori A, Cenderello G, Guerra M, De Leo P, Bartolacci V, Mantia E, Orofino G, Giacomini M, Bruzzone B, Francisci D, Di Biagio A; MARHIV Study Group.

Int J STD AIDS. 2017 Oct;28(11):1067-1073. doi: 10.1177/0956462416687828. Epub 2017 Jan 31.

PMID:
28142395
22.

An unexpected waterborne traveller.

Riccardi N, Cenderello G, Costa M, Cassola G.

Infection. 2017 Jun;45(3):391-392. doi: 10.1007/s15010-016-0979-7. Epub 2017 Jan 6. No abstract available.

PMID:
28063127
23.

Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting.

Marinaro L, Calcagno A, Ripamonti D, Cenderello G, Pirriatore V, Trentini L, Salassa B, Bramato C, Orofino G, D'Avolio A, Rizzi M, Di Perri G, Rusconi S, Bonora S.

J Clin Virol. 2017 Feb;87:30-36. doi: 10.1016/j.jcv.2016.11.015. Epub 2016 Dec 1.

PMID:
27992788
24.

Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides.

Di Biagio A, Riccardi N, Taramasso L, Capetti A, Cenderello G, Signori A, Vitiello P, Guerra M, de Socio GV, Cassola G, Quirino T, Viscoli C.

Int J Antimicrob Agents. 2016 Nov;48(5):551-554. doi: 10.1016/j.ijantimicag.2016.07.009. Epub 2016 Aug 17.

PMID:
27566908
25.

Salvage therapy or simplification of salvage regimens with dolutegravir plus ritonavir-boosted darunavir dual therapy in highly cART-experienced subjects: an Italian cohort.

Capetti AF, Sterrantino G, Cossu MV, Cenderello G, Cattelan AM, De Socio GV, Rusconi S, Riccardi N, Baldin GM, Cima S, Niero FP, Rizzardini G, Sasset L.

Antivir Ther. 2017;22(3):257-262. doi: 10.3851/IMP3095. Epub 2016 Sep 23.

PMID:
27661787
26.

Increasing use and accessibility of anti parasitic drugs for migrants with neglected diseases at a time of migratory emergency.

Cenderello G, Di Biagio A, Riccardi N, Taramasso L, De Maria A, Cassola G, Viscoli C.

New Microbiol. 2016 Oct;39(4):299-300. Epub 2016 Aug 23.

27.

Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection.

Cenderello G, Taramasso L, Riccardi N, Di Biagio A, Cassola G, De Maria A.

Clin Infect Dis. 2016 May 15;62(10):1323. doi: 10.1093/cid/ciw087. Epub 2016 Feb 16. No abstract available.

PMID:
26908811
28.

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation.

Cenderello G, Artioli S, Viscoli C, Pasa A, Giacomini M, Giannini B, Dentone C, Nicolini LA, Cassola G, Di Biagio A.

Clinicoecon Outcomes Res. 2015 Dec 31;8:15-21. doi: 10.2147/CEOR.S93641. eCollection 2016.

29.

Comparison of the In Vivo Pharmacokinetics and In Vitro Dissolution of Branded Versus Generic Efavirenz Formulation in HIV-Infected Patients.

Gervasoni C, Baldelli S, Cerea M, Cenderello G, Bini T, Vimercati S, Iardino R, Gazzaniga A, DʼArminio Monforte A, Clementi E, Cattaneo D.

Ther Drug Monit. 2016 Jun;38(3):420-2. doi: 10.1097/FTD.0000000000000273. No abstract available.

PMID:
26727626
30.

Quality of Life Among Hiv Patients: Results from the Ianua Clinical Trial.

Ameri M, Cassola G, Cenderello G, Di Biagio A, Giacomini M, Giannini B, Mazzarello G, Merlano C, Montefiori M, Orcamo P, Setti M, Viscoli C.

Value Health. 2015 Nov;18(7):A592. doi: 10.1016/j.jval.2015.09.1525. Epub 2015 Oct 20. No abstract available.

31.

Budget Impact Analysis of Sofosbuvir-Based Regimens for The Treatment of Hiv/Hcv Co-Infected Patients In Northern Italy: The Liguria Region Simulation.

Cenderello G, Artioli S, Gaggero D, Pasa A, Dentone C, Fraguglia C, Giacomini M, Giannini B, Pastorino G, Viscoli C, Cassola G, Di Biagio A.

Value Health. 2015 Nov;18(7):A579-80. doi: 10.1016/j.jval.2015.09.1933. Epub 2015 Oct 20. No abstract available.

32.

Appropriateness Score and Cost Evaluation In Hiv: The Aprosce System, on Field Clinical Evaluation.

Gaggero D, Marra D, Giacomini M, Giannini B, Fraguglia C, Cenderello G, Cassola G.

Value Health. 2015 Nov;18(7):A577. doi: 10.1016/j.jval.2015.09.1920. Epub 2015 Oct 20. No abstract available.

33.

Discordant responses to cART in HIV-1 patients in the era of high potency antiretroviral drugs: clinical evaluation, classification, management prospects.

Cenderello G, De Maria A.

Expert Rev Anti Infect Ther. 2016;14(1):29-40. doi: 10.1586/14787210.2016.1106937. Epub 2015 Oct 29. Review.

PMID:
26513236
34.

Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.

Sticchi L, Di Biagio A, Sartini M, Rappazzo E, Nicolini LA, Cenderello G, Valle C, Azzola E, Grasso A, De Leo P, Boldrini A, Setti M, Prinapori R, Lorusso C, Bruzzone B, Icardi G; Ligurian HIV Network.

New Microbiol. 2015 Oct;38(4):499-509. Epub 2015 Oct 20.

35.

'Emergency exit' of bone-marrow-resident CD34(+)DNAM-1(bright)CXCR4(+)-committed lymphoid precursors during chronic infection and inflammation.

Bozzano F, Marras F, Ascierto ML, Cantoni C, Cenderello G, Dentone C, Di Biagio A, Orofino G, Mantia E, Boni S, De Leo P, Picciotto A, Braido F, Antonini F, Wang E, Marincola F, Moretta L, De Maria A.

Nat Commun. 2015 Oct 5;6:8109. doi: 10.1038/ncomms9109.

36.

Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics.

Calcagno A, Montrucchio C, Capetti A, Guaraldi G, Cenderello G, Calza L, Lanzafame M, Marinaro L, Tettoni MC, Trentini L, D'Avolio A, Di Perri G, Bonora S.

Curr HIV Res. 2016;14(1):54-60.

PMID:
26415700
37.

Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous system.

Dentone C, Fenoglio D, Schenone E, Cenderello G, Prinapori R, Signori A, Parodi A, Kalli F, Battaglia F, Feasi M, Bruzzone B, Viscoli C, Filaci G, Di Biagio A.

HIV Clin Trials. 2015 Oct;16(5):190-6. doi: 10.1179/1945577115Y.0000000005. Epub 2015 Sep 13.

PMID:
26365593
38.

IANUA: a regional project for the determination of costs in HIV-infected patients.

Giannini B, Gazzarata R, Orcamo P, Merlano C, Cenderello G, Venturini A, Di Biagio A, Mazzarello G, Montefiori M, Ameri M, Setti M, Viscoli C, Cassola G, Giacomini M.

Stud Health Technol Inform. 2015;210:241-5.

PMID:
25991142
39.

Diagnostic value of MRI proton density fat fraction for assessing liver steatosis in chronic viral C hepatitis.

Paparo F, Cenderello G, Revelli M, Bacigalupo L, Rutigliani M, Zefiro D, Cevasco L, Amico M, Bandelloni R, Cassola G, Forni GL, Rollandi GA.

Biomed Res Int. 2015;2015:758164. doi: 10.1155/2015/758164. Epub 2015 Mar 19.

40.

Inpatient admissions of patients living with HIV in two European centres (UK and Italy); comparisons and contrasts.

Cenderello G, Tittle V, Pasa A, Dentone C, Artioli S, Setti M, Giacomini M, Fraccaro P, Viscoli C, Cassola G, Di Biagio A, Barbour A, Nelson M.

J Infect. 2015 Jun;70(6):690-4. doi: 10.1016/j.jinf.2014.12.009. Epub 2015 Jan 5. No abstract available.

PMID:
25572999
41.

Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort.

Tontodonati M, Cenderello G, Celesia BM, Trezzi M, Ursini T, Costantini A, Marra D, Polilli E, Catalani C, Butini L, Sozio F, Mazzotta E, Sciacca A, Rizzardini G, Manzoli L, Cozzi-Lepri A, Parruti G.

Clinicoecon Outcomes Res. 2014 Dec 22;7:27-35. doi: 10.2147/CEOR.S69183. eCollection 2015.

42.

Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL.

Dentone C, Fenoglio D, Signori A, Cenderello G, Parodi A, Bozzano F, Guerra M, De Leo P, Bartolacci V, Mantia E, Orofino G, Kalli F, Marras F, Fraccaro P, Giacomini M, Cassola G, Bruzzone B, Ferrea G, Viscoli C, Filaci G, De Maria A, Di Biagio A.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19718. doi: 10.7448/IAS.17.4.19718. eCollection 2014.

43.

A comparison of inpatient admissions in 2012 from two European countries.

Tittle V, Cenderello G, Pasa A, Patel P, Artioli S, Dentone C, Fraccaro P, Giacomini M, Setti M, Di Biagio A, Nelson M.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19712. doi: 10.7448/IAS.17.4.19712. eCollection 2014.

44.

Prevalence and predictors of malignancies in a polycentric cohort of HIV patients from Italy.

Mazzotta E, Tontodonati M, Gabrielli C, Mazzocato S, Mazzetti M, Falasca K, Cenderello G, Vecchiet J, Barchiesi F, Francisci D, Parruti G.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19652. doi: 10.7448/IAS.17.4.19652. eCollection 2014.

45.

Quality of life of people living with HIV, preliminary results from IANUA (Investigation on Antiretroviral Therapy) study.

Venturini A, Giannini B, Montefiori M, Di Biagio A, Mazzarello G, Cenderello G, Giacomini M, Merlano C, Orcamo P, Setti M, Viscoli C, Cassola G.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19581. doi: 10.7448/IAS.17.4.19581. eCollection 2014.

46.

Individualized treatment of genotype 1 naïve patients: an Italian multicenter field practice experience.

Mangia A, Cenderello G, Orlandini A, Piazzolla V, Picciotto A, Zuin M, Ciancio A, Brancaccio G, Forte P, Carretta V, Zignego AL, Minerva N, Brindicci G, Marignani M, Baroni GS, Bertino G, Cuccorese G, Mottola L, Ripoli M, Pirisi M.

PLoS One. 2014 Oct 23;9(10):e110284. doi: 10.1371/journal.pone.0110284. eCollection 2014.

47.

The ligurian human immunodeficiency virus clinical network: a web tool to manage patients with human immunodeficiency virus in primary care and multicenter clinical trials.

Fraccaro P, Pupella V, Gazzarata R, Dentone C, Cenderello G, De Leo P, Bozzano F, Casalino Finocchio G, De Maria A, Fenoglio D, Filaci G, Guerra M, Di Biagio A, Mantia E, Orofino G, Ferrea G, Viscoli C, Giacomini M.

Med 2 0. 2013 Aug 13;2(2):e5. doi: 10.2196/med20.2712. eCollection 2013 Jul-Dec.

48.

Unusual presentation of visceral leishmaniasis in an HIV-infected patient.

Cenderello G, Pontali E, Ruggeri C, Dusi A, De Maria A.

AIDS Res Hum Retroviruses. 2014 Sep;30(9):846-7. doi: 10.1089/AID.2014.0118. Epub 2014 Aug 20. No abstract available.

PMID:
25054214
49.

Interleukin-28B genetic variants in untreated Italian HCV-infected patients: a multicentre study.

Mottola L, Cenderello G, Piazzolla VA, Forte P, Carretta V, Mecenate F, Brancaccio G, Minisini R, Zuin M, Terreni N, Monti M, Colombo AE, Nosotti L, Minerva N, Luzzitelli I, Kostandini A, Cuccorese G, Russello M, Santoro R, Mangia A.

Liver Int. 2015 Feb;35(2):482-8. doi: 10.1111/liv.12630. Epub 2014 Jul 17.

PMID:
25039676
50.

Real-time elastography in the assessment of liver fibrosis: a review of qualitative and semi-quantitative methods for elastogram analysis.

Paparo F, Corradi F, Cevasco L, Revelli M, Marziano A, Molini L, Cenderello G, Cassola G, Rollandi GA.

Ultrasound Med Biol. 2014 Sep;40(9):1923-33. doi: 10.1016/j.ultrasmedbio.2014.03.021. Epub 2014 Jun 25. Review.

Supplemental Content

Loading ...
Support Center